ciprofloxacin has been researched along with Hepatitis C, Chronic in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, H | 1 |
| Kaita, KD | 1 |
| Hawkins, K | 1 |
| Uhanova, J | 1 |
| Minuk, GY | 1 |
1 trial available for ciprofloxacin and Hepatitis C, Chronic
| Article | Year |
|---|---|
Use of fluoroquinolones in patients with chronic hepatitis C virus-induced liver failure.
Topics: Alanine Transaminase; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Hepatitis C, Chroni | 2002 |